Telix Pharmaceuticals Lim...

NASDAQ: TLX · Real-Time Price · USD
11.29
-0.61 (-5.13%)
At close: Aug 19, 2025, 3:59 PM
11.25
-0.35%
After-hours: Aug 19, 2025, 07:55 PM EDT

Telix Pharmaceuticals Revenue Breakdown

Period Ending Dec 31, 2018
Digital Product Sales Revenue 35.87M
Digital Product Sales Revenue Growth n/a
Digital Product Lease And Maintenance Revenue 4.88M
Digital Product Lease And Maintenance Revenue Growth n/a

Revenue by Geography

Period Ending Dec 31, 2024
Australia Revenue 1.22M
Australia Revenue Growth n/a
Belgium Revenue 546K
Belgium Revenue Growth n/a
Canada Revenue 2.54M
Canada Revenue Growth n/a
United States Revenue 762.31M
United States Revenue Growth n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021 Dec 31, 2020 Jun 30, 2020 Dec 31, 2019 Jun 30, 2019 Dec 31, 2018 Jun 30, 2018 Dec 31, 2017 Jun 30, 2017 Jan 31, 2017 Jun 30, 2016 Dec 31, 2015 Jun 30, 2015
Selling, General, and Administrative Revenue 168.61M 64.25M 105.5M 28.93M 21.58M 23.08M 10.59M 6.75M 6.41M 2.88M 5.04M 2.17M 5.14M 4M 2.77M 1.55M 667.82K -647.82K 27K 27K
Selling, General, and Administrative Revenue Growth +162.42% -39.10% +264.73% +34.03% -6.49% +117.87% +56.84% +5.35% +122.60% -42.91% +131.95% -57.69% +28.39% +44.64% +78.64% +131.99% -203.09% -2499.31% 0.00% n/a
Research and Development Revenue 148.85M 45.78M 98.4M 30.45M 33.01M 24.84M 20.46M 13.67M 14.48M 8.61M 13.32M 7.84M 12.24M 6.45M 2.18M 1.6M 744.26K -734.26K 31K 31K
Research and Development Revenue Growth +225.13% -53.47% +223.17% -7.78% +32.89% +21.39% +49.71% -5.59% +68.27% -35.41% +69.93% -35.94% +89.63% +196.71% +35.62% +115.49% -201.36% -2468.60% 0.00% n/a
Sales and Marketing Revenue 115.2M n/a 49.26M 5.6M 27.61M 10.36M 3.5M 2.39M 1.03M 173K 127K 185K 16.57K 55.43K 144.49K 106.88K 53.44K -53.44K n/a n/a
Sales and Marketing Revenue Growth n/a -100.00% +779.07% -79.70% +166.51% +195.66% +46.80% +131.97% +494.80% +36.22% -31.35% +1016.34% -70.10% -61.64% +35.18% +100.00% -200.00% n/a n/a n/a